NO992226D0 - Nye forbindelser for anvendelse som neuro-protektive midler - Google Patents
Nye forbindelser for anvendelse som neuro-protektive midlerInfo
- Publication number
- NO992226D0 NO992226D0 NO992226A NO992226A NO992226D0 NO 992226 D0 NO992226 D0 NO 992226D0 NO 992226 A NO992226 A NO 992226A NO 992226 A NO992226 A NO 992226A NO 992226 D0 NO992226 D0 NO 992226D0
- Authority
- NO
- Norway
- Prior art keywords
- new compounds
- neuroprotective agents
- agents
- neuroprotective
- oxazolines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D263/57—Aryl or substituted aryl radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D263/14—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/26—Radicals substituted by sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Adhesives Or Adhesive Processes (AREA)
- Liquid Crystal Substances (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2756096P | 1996-10-07 | 1996-10-07 | |
PCT/US1997/017963 WO1998015274A1 (en) | 1996-10-07 | 1997-10-06 | Novel compounds useful as neuro-protective agents |
Publications (3)
Publication Number | Publication Date |
---|---|
NO992226D0 true NO992226D0 (no) | 1999-05-07 |
NO992226L NO992226L (no) | 1999-05-27 |
NO313193B1 NO313193B1 (no) | 2002-08-26 |
Family
ID=21838447
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19992226A NO313193B1 (no) | 1996-10-07 | 1999-05-07 | Nye forbindelser for anvendelse som neuro-protektive midler |
Country Status (19)
Country | Link |
---|---|
US (4) | US6156748A (no) |
EP (1) | EP0971709B1 (no) |
CN (1) | CN1239889A (no) |
AT (1) | ATE240728T1 (no) |
AU (1) | AU721355B2 (no) |
CA (1) | CA2270661A1 (no) |
CZ (1) | CZ166399A3 (no) |
DE (1) | DE69722258T2 (no) |
DK (1) | DK0971709T3 (no) |
EA (1) | EA001713B1 (no) |
ES (1) | ES2199353T3 (no) |
HU (1) | HUP9904682A3 (no) |
ID (1) | ID21472A (no) |
IL (1) | IL129748A (no) |
NO (1) | NO313193B1 (no) |
NZ (1) | NZ335610A (no) |
PT (1) | PT971709E (no) |
TR (1) | TR199901559T2 (no) |
WO (1) | WO1998015274A1 (no) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5942530A (en) * | 1997-08-28 | 1999-08-24 | Eli Lilly And Company | Method for treating pain |
AU9034798A (en) * | 1997-08-28 | 1999-03-16 | Eli Lilly And Company | Method for treating pain |
US5952360A (en) * | 1997-08-28 | 1999-09-14 | Eli Lilly And Company | Method for treating neuropathic pain |
TR200100352T2 (tr) | 1997-10-06 | 2001-06-21 | Eli Lilly And Company | Nöro-koruyucu maddeler olarak yararlı yeni bileşikler |
DE19816880A1 (de) * | 1998-04-17 | 1999-10-21 | Boehringer Ingelheim Pharma | Neue Diphenyl-substituierte 5-Ring-Heterocyclen, Verfahren zu ihrer Herstellung sowie deren Verwendung als Arzneimittel |
EP1218336A2 (en) | 1999-09-20 | 2002-07-03 | Takeda Chemical Industries, Ltd. | Melanin concentrating hormone antagonist |
FR2812546B1 (fr) * | 2000-08-01 | 2008-11-21 | Sod Conseils Rech Applic | Derives d'heterocycles a 5 chainons, leur preparation et leur application a titre de medicaments |
TWI283577B (en) * | 1999-10-11 | 2007-07-11 | Sod Conseils Rech Applic | Pharmaceutical composition of imidazole derivatives acting as modulators of sodium channels and the use thereof |
AU2001252596A1 (en) | 2000-04-28 | 2001-11-12 | Takeda Chemical Industries Ltd. | Melanin concentrating hormone antagonists |
US7144909B2 (en) * | 2001-02-08 | 2006-12-05 | Karo Bio Ab | Phenoxy substituted benzocondensed heteroaryl derivatives as thyroid receptor ligands |
US7091357B2 (en) * | 2001-12-26 | 2006-08-15 | University Of Kentucky Research Foundation | Chain-modified pyridino-N substituted nicotine compounds for use in the treatment of CNS pathologies |
WO2004005267A2 (en) | 2002-07-03 | 2004-01-15 | Janssen Pharmaceutica, N.V. | Heteroaryl compounds useful in treating inflammatory disorders |
EP3659618A1 (en) | 2003-02-04 | 2020-06-03 | Cornell Research Foundation, Inc. | Uses of aromatic-cationic peptide |
TW200505913A (en) | 2003-03-28 | 2005-02-16 | Hoffmann La Roche | Novel oxazole derivatives, their manufacture and use as pharmaceutical agents |
US7353897B2 (en) * | 2003-07-23 | 2008-04-08 | Fernandez Dennis S | Telematic method and apparatus with integrated power source |
CA2971928C (en) | 2004-01-23 | 2019-01-08 | Cornell Research Foundation, Inc. | Methods for reducing oxidative damage |
ES2483992T3 (es) | 2005-11-15 | 2014-08-08 | Otsuka Pharmaceutical Co., Ltd. | Compuesto oxazol y composición farmacéutica |
EA025178B1 (ru) | 2010-09-06 | 2016-11-30 | Айгис Аг | Проточный аккумулятор и способ преобразования электрической энергии с его использованием |
US10881162B2 (en) | 2015-05-07 | 2021-01-05 | Exero Labs LLC | Device for minimizing impact of collisions for a helmet |
WO2024040267A2 (en) * | 2022-08-19 | 2024-02-22 | Mitokinin, Inc. | Direct synthesis of n-(3-substituted-chroman-4-yl)-7h- pyrrolo[2,3-d]pyrimidin-4-amines and derivatives thereof |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4636516A (en) * | 1981-02-19 | 1987-01-13 | Yamanouchi Pharmaceutical Co., Ltd. | 3,5-di-tert-butyl-4-hydroxyphenyl-substituted heterocyclic compounds |
DE3425118A1 (de) * | 1984-07-07 | 1986-01-16 | Boehringer Mannheim Gmbh, 6800 Mannheim | Neue redox-indikatoren |
GB8531608D0 (en) * | 1985-12-23 | 1986-02-05 | Beecham Group Plc | Treatment |
DE3621775A1 (de) * | 1986-03-13 | 1988-01-07 | Thomae Gmbh Dr K | Neue substituierte thiazole und oxazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
CA2009470A1 (en) * | 1989-02-08 | 1990-08-08 | Yu Momose | Oxazole compounds and their use |
DE3903993A1 (de) * | 1989-02-10 | 1990-08-16 | Basf Ag | Diarylsubstituierte heterocyclische verbindungen, ihre herstellung und arzneimittel daraus |
ATE142494T1 (de) * | 1990-11-30 | 1996-09-15 | Teijin Ltd | 2-arylthiazolderivat sowie dieses enthaltendes arzneimittel |
US5633271A (en) * | 1992-05-26 | 1997-05-27 | E. I. Du Pont De Nemours And Company | Arthropodicidal oxazolines and thiazolines |
DE4304197A1 (de) * | 1993-02-12 | 1994-08-18 | Bayer Ag | Substituierte Oxazole |
US5428048A (en) * | 1993-11-08 | 1995-06-27 | American Home Products Corporation | Aryl-N-hydroxyureas as inhibitors of 5-lipoxygenase and anto-arteriosclerotic agents |
US6251928B1 (en) * | 1994-03-16 | 2001-06-26 | Eli Lilly And Company | Treatment of alzheimer's disease employing inhibitors of cathepsin D |
US5952360A (en) * | 1997-08-28 | 1999-09-14 | Eli Lilly And Company | Method for treating neuropathic pain |
AU9034798A (en) * | 1997-08-28 | 1999-03-16 | Eli Lilly And Company | Method for treating pain |
US5942530A (en) * | 1997-08-28 | 1999-08-24 | Eli Lilly And Company | Method for treating pain |
TR200100352T2 (tr) * | 1997-10-06 | 2001-06-21 | Eli Lilly And Company | Nöro-koruyucu maddeler olarak yararlı yeni bileşikler |
-
1997
- 1997-10-06 CA CA002270661A patent/CA2270661A1/en not_active Abandoned
- 1997-10-06 EP EP97909975A patent/EP0971709B1/en not_active Expired - Lifetime
- 1997-10-06 IL IL12974897A patent/IL129748A/xx not_active IP Right Cessation
- 1997-10-06 ES ES97909975T patent/ES2199353T3/es not_active Expired - Lifetime
- 1997-10-06 DE DE69722258T patent/DE69722258T2/de not_active Expired - Fee Related
- 1997-10-06 WO PCT/US1997/017963 patent/WO1998015274A1/en not_active Application Discontinuation
- 1997-10-06 ID IDW990301A patent/ID21472A/id unknown
- 1997-10-06 PT PT97909975T patent/PT971709E/pt unknown
- 1997-10-06 DK DK97909975T patent/DK0971709T3/da active
- 1997-10-06 US US08/944,468 patent/US6156748A/en not_active Expired - Fee Related
- 1997-10-06 AU AU47459/97A patent/AU721355B2/en not_active Ceased
- 1997-10-06 EA EA199900362A patent/EA001713B1/ru not_active IP Right Cessation
- 1997-10-06 HU HU9904682A patent/HUP9904682A3/hu unknown
- 1997-10-06 AT AT97909975T patent/ATE240728T1/de not_active IP Right Cessation
- 1997-10-06 TR TR1999/01559T patent/TR199901559T2/xx unknown
- 1997-10-06 CN CN97180378A patent/CN1239889A/zh active Pending
- 1997-10-06 NZ NZ335610A patent/NZ335610A/xx unknown
- 1997-10-06 CZ CZ991663A patent/CZ166399A3/cs unknown
-
1999
- 1999-05-07 NO NO19992226A patent/NO313193B1/no not_active IP Right Cessation
- 1999-08-04 US US09/368,236 patent/US6166216A/en not_active Expired - Fee Related
-
2000
- 2000-11-17 US US09/715,987 patent/US6380213B1/en not_active Expired - Fee Related
-
2001
- 2001-11-28 US US09/996,005 patent/US6423709B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU721355B2 (en) | 2000-06-29 |
TR199901559T2 (xx) | 1999-09-21 |
US6380213B1 (en) | 2002-04-30 |
EP0971709B1 (en) | 2003-05-21 |
US6156748A (en) | 2000-12-05 |
US6423709B1 (en) | 2002-07-23 |
HUP9904682A2 (hu) | 2000-05-28 |
DK0971709T3 (da) | 2003-09-22 |
WO1998015274A1 (en) | 1998-04-16 |
AU4745997A (en) | 1998-05-05 |
EP0971709A1 (en) | 2000-01-19 |
ATE240728T1 (de) | 2003-06-15 |
NO313193B1 (no) | 2002-08-26 |
US6166216A (en) | 2000-12-26 |
IL129748A (en) | 2003-11-23 |
CZ166399A3 (cs) | 1999-11-17 |
DE69722258D1 (de) | 2003-06-26 |
CN1239889A (zh) | 1999-12-29 |
NZ335610A (en) | 2000-10-27 |
ES2199353T3 (es) | 2004-02-16 |
DE69722258T2 (de) | 2004-03-18 |
EA199900362A1 (ru) | 2000-02-28 |
NO992226L (no) | 1999-05-27 |
EA001713B1 (ru) | 2001-08-27 |
ID21472A (id) | 1999-06-17 |
IL129748A0 (en) | 2000-02-29 |
EP0971709A4 (en) | 2001-04-11 |
US20020065274A1 (en) | 2002-05-30 |
CA2270661A1 (en) | 1998-04-16 |
PT971709E (pt) | 2003-09-30 |
HUP9904682A3 (en) | 2001-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO992226L (no) | Nye forbindelser for anvendelse som neuro-protektive midler | |
TR200103612T2 (tr) | Tiazol ve oksazol türevleri ve farmasötik kullanımları | |
ATE293611T1 (de) | Thiazol und oxazol-derivate als aktivatoren von menschlichen peroxisom proliferator aktivierten rezeptoren | |
NO20054195D0 (no) | Isoksazolforbindelser som inhibitorer for varmesjokkproteiner | |
RS51343B (sr) | Nova kompozicija i njena upotreba | |
NO20022467L (no) | Substituerte oksazol- og tiazol-derivater som HPPAR-alfa- aktivatorer | |
DE59913784D1 (de) | Verwendung von Thiazolidinderivaten als antihyperglykämische Mittel | |
NO992492L (no) | Benzamidoaldehyder og deres anvendelse som cystein-protease-inhibitorer | |
TR199800679T2 (xx) | Kiral metil fenil oksazolidinon. | |
BR9509673A (pt) | Compostos e uso dos mesmos | |
DK0699192T3 (da) | Substituerede oxazolylforbindelser til behandling af inflammation | |
ATE264313T1 (de) | Substituierte oxazole und thiazole derivate als hppar-gamma und hppar-alpha aktivatore | |
NO20062629L (no) | Oksazolderivater av tetrackliner | |
DE60024414D1 (de) | Oxadiazolverbindungen und -zusammensetzungen zur abgabe von wirkstoffen | |
SE9702305D0 (sv) | New thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives | |
AR048948A1 (es) | Una composicion farmaceutica antimicobacteriana | |
NO20014855D0 (no) | N-(2-fenyl-4-aminobutyl)-1-naftamider som neurokinin-1- reseptorantagonister | |
TR200100352T2 (tr) | Nöro-koruyucu maddeler olarak yararlı yeni bileşikler | |
DE60136341D1 (de) | Oxazolidin tablettenformulierung | |
ES2060606T3 (es) | Utilizacion de derivados de oxazolidinonas 5-(fenil-sustituido) para el tratamiento de depresiones. | |
NO20032582D0 (no) | 1,2,4-oksadiazolderivater som HPPAR alfa agonister | |
DE69930952D1 (de) | Gesteuerte freisetzung von antidepressiva | |
ATE329913T1 (de) | Oxazole als mglur1 verstärker | |
DK1032386T3 (da) | Anvendelse af oxazolidinonderivater til behandling af arthritis | |
DE59703824D1 (de) | Sulfonylbenzazolone |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |